FindTrial
Sign In

Exploration and Research for a new method for detection of novel coronavirus (COVID-19) nucleic acid

Exploration and Research for a new method for detection of novel coronavirus (COVID-19) nucleic acid

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030253
Enrollment
Unknown
Registered
2020-02-26
Start date
2020-02-27
Completion date
Unknown
Last updated
2020-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Gold Standard:Detection of novel coronavirus by fluorescence RT-PCR
Index test:Detection&#32
of&#32
viral&#32
nucleic&#32
acids&#32
in&#32
eye&#32
swabs,&#32
throat&#32
oral&#32
saliva,&#32
feces,&#32
urine&#32
and&#32
plasma

Sponsors

Ganzi Hospital of West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: suspected infection and Confirmed novel coronavirus patients

Exclusion criteria

Exclusion criteria: Non Novel coronavirus suspected infection and Confirmed patients

Design outcomes

Primary

MeasureTime frame
SEN, SPE, ACC, AUC of ROC;—

Countries

China

Contacts

Public ContactLijia Deng

Ganzi Hospital of West China Hospital, Sichuan University

27216302@qq.com+86 17723451376

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026